60 likes | 228 Views
Global Markets Direct's, ‘Osteoarthritis Pain - Pipeline Review, H1 2015', provides an overview of the Osteoarthritis Pain's therapeutic pipeline. Inquire more about this Report at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=394554 . (This is a premium report price at US$2000 for a single user PDF license)
E N D
Osteoarthritis Pain Therapeutic Pipeline Review, H1 2015 By RnRMarketResearch Browse more reports on Pain Management at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/pain-management . (This is a premium report price at US$2000 for a single user PDF license) ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
Osteoarthritis Pain Therapeutic Pipeline Review, H1 2015 Global Markets Direct's, ‘Osteoarthritis Pain - Pipeline Review, H1 2015', provides an overview of the Osteoarthritis Pain's therapeutic pipeline. Osteoarthritis is a disease which is caused by ebbing of the joint cartilage and the formation of new bone at the joints. There are number of Drugs and medications to cover it. A-889425, ADX-71441, Ampion, AS-288640100 are some of the Drugs Profile which are Included in this Report. The Company Mentioned in this report Is Addex Therapeutics Ltd, Afferent Pharmaceuticals, Inc, Ampio Pharmaceuticals, Inc., Antibe Therapeutics, Inc., Bone Medical Limited, etc ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
Osteoarthritis Pain Therapeutic Pipeline Review, H1 2015 The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. This report provides comprehensive information on the therapeutic development for Osteoarthritis Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Osteoarthritis Pain and special features on late-stage and discontinued projects. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
Osteoarthritis Pain Therapeutic Pipeline Review, H1 2015 Scope: • The report provides a snapshot of the global therapeutic landscape of Osteoarthritis Pain • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities • The report reviews key players involved in the therapeutics development for Osteoarthritis Pain and enlists all their major and minor projects • The report summarizes all the dormant and discontinued pipeline projects ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
Osteoarthritis Pain Therapeutic Pipeline Review, H1 2015 Reasons to Buy: • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage • Develop strategic initiatives by understanding the focus areas of leading companies • Identify and understand important and diverse types of therapeutics under development for Osteoarthritis Pain ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441
Osteoarthritis Pain Therapeutic Pipeline Review, H1 2015 For more details contact Mr. Ritesh Tiwari :sales@rnrmarketresearch.com/ +18883915441 RnRMarkertResearch RnRMarketResearch.com, an online repository of market research reports, offers in-depth analysis of over 5000 market segments. RnRMarket Research library has syndicated reports by leading market research publishers across the globe. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441